Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
Completed · Phase 2
Conditions studied: Bladder Cancer, Urethral Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as cisplatin, ifosfamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating patients with metastatic urinary tract cancer that cannot be treated with surgery.
Key facts
- Study ID
- NCT00002684
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 40
- Starts
- 1995-05-01
- Expected to finish
- 2007-10-01
- Last updated by the study team
- 2013-07-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.